Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.

Martini DJ, Olsen TA, Goyal S, Liu Y, Evans ST, Hitron EE, Russler GA, Yantorni L, Caulfield S, Brown JT, Goldman JM, Nazha B, Carthon BC, Harris WB, Kucuk O, Master VA, Bilen MA

Open source

DOI
10.36401/jipo-22-2
Published
2022 Aug
Container
Journal of immunotherapy and precision oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.36401/jipo-22-2,
  title = {Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.},
  author = {Martini DJ and Olsen TA and Goyal S and Liu Y and Evans ST and Hitron EE and Russler GA and Yantorni L and Caulfield S and Brown JT and Goldman JM and Nazha B and Carthon BC and Harris WB and Kucuk O and Master VA and Bilen MA},
  year = {2022},
  journal = {Journal of immunotherapy and precision oncology},
  doi = {10.36401/jipo-22-2},
  url = {https://doi.org/10.36401/jipo-22-2}
}

RIS

TY  - JOUR
TI  - Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.
AU  - Martini DJ
AU  - Olsen TA
AU  - Goyal S
AU  - Liu Y
AU  - Evans ST
AU  - Hitron EE
AU  - Russler GA
AU  - Yantorni L
AU  - Caulfield S
AU  - Brown JT
AU  - Goldman JM
AU  - Nazha B
AU  - Carthon BC
AU  - Harris WB
AU  - Kucuk O
AU  - Master VA
AU  - Bilen MA
PY  - 2022
JO  - Journal of immunotherapy and precision oncology
DO  - 10.36401/jipo-22-2
UR  - https://doi.org/10.36401/jipo-22-2
ER  - 

APA

DJ, M., TA, O., S, G., Y, L., ST, E., EE, H., GA, R., L, Y., S, C., JT, B., JM, G., B, N., BC, C., WB, H., O, K., VA, M., & MA, B. (2022). Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.. Journal of immunotherapy and precision oncology. https://doi.org/10.36401/jipo-22-2

Source records